Laboratorial methods
Respiratory samples (nasopharynx swab and/or tracheal aspirates) were
submitted to molecular analysis at the Molecular Biology Laboratory
HCFMUSP: Fast-track Diagnostics® (Panel 21), detects 21 respiratory
pathogens: adenovirus, bocavirus, coronavirus (229E; HKU1; NL63; OC43),
human rhinovirus/enterovirus, influenza virus A (H1N1, H3N2, Influenza A
H1N1/2009), influenza virus B, Influenza virus C, metapneumovirus A e B,
Mycoplasma pneumoniae, parainfluenza virus (1-4), parechovirus,
respiratory syncytial virus (RSV) A and B.(5) RT-PCR for SARS-CoV-2
analysis was performed, according to the Charité University protocol.(6)
Serology was performed at the HCFMUSP Immunology Laboratory by
imunocromatographic test (SARS-CoV-2 antibody test® WONDFO) or by enzyme
linked immunosorbent assay
(LIAISON®
XL | DiaSorin).(4)